Cronos Group Inc (CRON)
2.03
-0.04
(-1.93%)
USD |
NASDAQ |
Nov 15, 15:31
Cronos Group Total Assets (Quarterly): 1.091B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.091B |
| March 31, 2024 | 1.109B |
| December 31, 2023 | 1.140B |
| September 30, 2023 | 1.150B |
| June 30, 2023 | 1.168B |
| March 31, 2023 | 1.160B |
| December 31, 2022 | 1.213B |
| September 30, 2022 | 1.237B |
| June 30, 2022 | 1.332B |
| March 31, 2022 | 1.371B |
| December 31, 2021 | 1.398B |
| September 30, 2021 | 1.535B |
| June 30, 2021 | 1.839B |
| March 31, 2021 | 1.881B |
| December 31, 2020 | 1.926B |
| September 30, 2020 | 1.919B |
| June 30, 2020 | 1.910B |
| March 31, 2020 | 1.928B |
| December 31, 2019 | 2.090B |
| September 30, 2019 | 2.087B |
| Date | Value |
|---|---|
| June 30, 2019 | 2.032B |
| March 31, 2019 | 2.021B |
| December 31, 2018 | 183.47M |
| September 30, 2018 | 181.46M |
| June 30, 2018 | 179.01M |
| March 31, 2018 | 108.59M |
| December 31, 2017 | 80.34M |
| September 30, 2017 | 64.02M |
| June 30, 2017 | 42.37M |
| March 31, 2017 | 43.95M |
| December 31, 2016 | 31.92M |
| September 30, 2016 | 30.13M |
| June 30, 2016 | 12.14M |
| March 31, 2016 | 10.69M |
| December 31, 2015 | 10.61M |
| September 30, 2015 | 7.091M |
| June 30, 2015 | 8.077M |
| March 31, 2015 | 7.420M |
| September 30, 2014 | 0.6613M |
| June 30, 2014 | 0.2348M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.091B
Minimum
Jun 2024
2.090B
Maximum
Dec 2019
1.495B
Average
1.371B
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Tilray Brands Inc | 4.262B |
| Aurinia Pharmaceuticals Inc | 549.36M |
| Edesa Biotech Inc | 5.228M |
| Lexaria Bioscience Corp | 10.02M |
| Xenon Pharmaceuticals Inc | 884.01M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 35.26M |
| Shareholders Equity (Quarterly) | 1.059B |
| Current Ratio | 28.29 |